Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002379731 | SCV002689878 | uncertain significance | Cardiovascular phenotype | 2021-06-22 | criteria provided, single submitter | clinical testing | The p.I4488T variant (also known as c.13463T>C), located in coding exon 29 of the APOB gene, results from a T to C substitution at nucleotide position 13463. The isoleucine at codon 4488 is replaced by threonine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002491570 | SCV002779128 | uncertain significance | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2021-09-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002491570 | SCV004604248 | benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2024-01-24 | criteria provided, single submitter | clinical testing |